Pfizer to buy Global Blood Therapeutics in $5.4bn cash deal – Prompt News

Monday, 8 August 2022, 16:29:56
U.S. pharmaceutical maker Pfizer and Biopharmaceutical Company Global Blood Therapeutics (GBT) on Monday agreed that Pfizer will acquire GBT in an all-cash deal valued at 5.4 billion U.S. dollars. Pfizer said the acquisition would drive growth by enhancing its work in rare hematology while reinforcing the company’s commitment to sickle cell disease research and treatment.
— Prompt News Online

International Ekonomie: Pfizer keeft Global Blood Therapeutics fir 5,3 Milliarden Euro

Monday, 8 August 2022, 16:27:54
Den US-amerikanesche Pharmakonzern Pfizer ass domadder bereet, 68,50 US-Dollar pro Aktie an de Kaf vu Global Blood Therapeutics (GBT) z”investéieren.
— RTL Luxembourg

Oxbryta: Pfizer to acquire sickle cell drugmaker GBT for $5 bn

Monday, 8 August 2022, 16:21:50
…
— RTL Today

Pfizer to buy Global Blood Therapeutics

Monday, 8 August 2022, 15:52:20
Pfizer Inc. has agreed to buy Global Blood Therapeutics Inc., the maker of a drug for sickle-cell disease, in a deal worth $5.4 billion, Report informs via Bloomberg.
— Report AZ

Pfizer to Buy Global Blood Therapeutics

Monday, 8 August 2022, 15:48:00
Pfizer Inc (NYSE:PFE) is boosting its pipeline with a $5.4-billion deal for blood disorder drugmaker Global Blood Therapeutics (NASDAQ:GBT), the latest in a series of acquisitions to combat a potential slowdown in COVID-19 products demand as cases fall. Pfizer …
— Baystreet Canada